Finance

Lists
NMRA:NASDAQ
Neumora Therapeutics Inc
US$0,47
0,00%
(0,00) 1D
US$0,48
+2,50% (+0,012)
Pre-market
Closed: 7 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NMRA...
Mkt. cap
88,18 ລ້ານ
Avg. vol.
1,68 ລ້ານ
Volume
3,71 ພັນ
52-wk high
US$3,65
52-wk low
US$0,45
EPS
US$-1,23
Beta
2,95
Shares outstanding
187,90 ລ້ານ
No. of employees
63
Mkt. cap
88,18 ລ້ານ
Avg. vol.
1,68 ລ້ານ
Volume
3,71 ພັນ
52-wk high
US$3,65
52-wk low
US$0,45
EPS
US$-1,23
Beta
2,95
Shares outstanding
187,90 ລ້ານ
No. of employees
63
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
19 ນາທີກ່ອນ
Nexalin Technology Regains Compliance with Nasdaq Minimum
Yahoo Finance
Yahoo Finance
·
25 ນາທີກ່ອນ
1 S&P 500 Stock to Consider Right Now and 2 That Underwhelm
About Neumora Therapeutics Inc
CEO-
Employees63
Founded2019
HeadquartersWatertown, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to NMRA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NMRA in the last 3 months.
Highest
Current US$0,47
US$7,00 (+1.394,77%)
Average
US$5,25 (+1.021,08%)
Lowest
US$4,00 (+754,15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
US$7,00
+1.394,8%
08/24/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
US$4,00
+754,2%
08/17/2026
Ami Fadia
Needham
Buy
Reiterated
US$5,00
+967,7%
08/14/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
08/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
US$5,00
+967,7%
08/14/2026
Tessa Romero
J.P. Morgan
Sell
Maintained
-
-
05/26/2026
Paul Matteis
Stifel Nicolaus
Hold
Maintained
US$3,00
+540,6%
05/12/2026
Yatin Suneja
Guggenheim
Buy
Maintained
US$14,00
+2.889,5%
05/07/2026
Last report
14 ສ.ຫ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$-0,23 / US$-0,24
+5,34%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
40,52 ລ້ານ
44,67 ລ້ານ
38,60 ລ້ານ
29,28 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,18 ລ້ານ
13,81 ລ້ານ
14,27 ລ້ານ
12,91 ລ້ານ
Operating expense
52,70 ລ້ານ
58,48 ລ້ານ
52,86 ລ້ານ
42,19 ລ້ານ
Total operating expenses
52,70 ລ້ານ
58,48 ລ້ານ
52,86 ລ້ານ
42,19 ລ້ານ
Operating income
-52,70 ລ້ານ
-58,48 ລ້ານ
-52,86 ລ້ານ
-42,19 ລ້ານ
Other non operating income
7,00 ພັນ
-269,00 ພັນ
59,00 ພັນ
-7,00 ພັນ
EBT including unusual items
-56,76 ລ້ານ
-59,45 ລ້ານ
-53,43 ລ້ານ
-43,08 ລ້ານ
EBT excluding unusual items
-51,76 ລ້ານ
-59,45 ລ້ານ
-53,43 ລ້ານ
-43,08 ລ້ານ
Income tax expense
-
-
30,00 ພັນ
-
Effective tax rate
-
-
-0,06%
-
Other operating expenses
-
-
-
-
Net income
-56,76 ລ້ານ
-59,45 ລ້ານ
-53,46 ລ້ານ
-43,08 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,35
-0,35
-0,30
-0,23
Interest and investment income
1,68 ລ້ານ
1,34 ລ້ານ
1,23 ລ້ານ
935,00 ພັນ
Interest expense
-747,00 ພັນ
-2,04 ລ້ານ
-1,85 ລ້ານ
-1,82 ລ້ານ
Net interest expenses
938,00 ພັນ
-701,00 ພັນ
-623,00 ພັນ
-885,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-52,68 ລ້ານ
-58,47 ລ້ານ
-52,86 ລ້ານ
-42,18 ລ້ານ
Gain or loss from assets sale
-62,00 ພັນ
264,00 ພັນ
-71,00 ພັນ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google